Abiopharma

🔍 LYNCH G PATRICK (Director)

Company: NORTHERN TECHNOLOGIES INTERNATIONAL CORP (NTIC)

Report Date: 2026-07-29

Detailed Transactions and Holdings:

• Acquired 16,072 shares of Common Stock at $6.7 per share (Direct)
  Date: 2026-07-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 121,356.00 | transaction_form_type: 4
• Sold 2 shares of Common Stock at $8.1 per share (Direct)
  Date: 2026-07-29 | Code: S | equity_swap_involved: 0 | shares_owned_after: 121,354.00 | transaction_form_type: 4
• Sold 16,070 shares of Common Stock at $7.9967 per share (Direct)
  Date: 2026-07-30 | Code: S | equity_swap_involved: 0 | shares_owned_after: 105,284.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-29 | Code: H | nature_of_ownership: (2) | shares_owned_after: 1,203,334.00 | Footnotes: F2
• Sold 16,072 shares of Stock Option (right to buy) at $6.7 per share (Derivative)
  Date: 2026-07-29 | Code: M | Expires: 2026-08-31 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.95 to $8.05, inclusive. The reporting person undertakes to provide to Northern Technologies International Corporation (NTIC), any security holder of NTIC, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
• F2: These shares are held directly by Inter Alia Holding Company of which G. Patrick Lynch is an officer and stockholder. Mr. G. Patrick Lynch disclaims beneficial ownership of the shares held by Inter Alia Holding Company, except to the extent of his pecuniary interest therein.
• F3: This option has fully vested.